Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2004 4
2005 3
2006 9
2008 6
2009 1
2010 8
2011 3
2012 3
2013 1
2014 3
2015 4
2016 3
2018 2
2019 2
2021 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk; RECOVERY Collaborative Group. RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, et al. Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13. Lancet. 2023. PMID: 37060915 Free PMC article. Clinical Trial.
The frequency of pathogenic variation in the All of Us cohort reveals ancestry-driven disparities.
Venner E, Patterson K, Kalra D, Wheeler MM, Chen YJ, Kalla SE, Yuan B, Karnes JH, Walker K, Smith JD, McGee S, Radhakrishnan A, Haddad A, Empey PE, Wang Q, Lichtenstein L, Toledo D, Jarvik G, Musick A, Gibbs RA; All of Us Research Program Investigators. Venner E, et al. Commun Biol. 2024 Feb 19;7(1):174. doi: 10.1038/s42003-023-05708-y. Commun Biol. 2024. PMID: 38374434 Free PMC article.
Molecular therapeutics: promise and challenges.
Kohn EC, Lu Y, Wang H, Yu Q, Yu S, Hall H, Smith DL, Meric-Bernstam F, Hortobagyi GN, Mills GB. Kohn EC, et al. Among authors: smith dl. Semin Oncol. 2004 Feb;31(1 Suppl 3):39-53. doi: 10.1053/j.seminoncol.2004.01.009. Semin Oncol. 2004. PMID: 15052542 Review.
The contribution of Langerhans cells to cutaneous malignancy.
Lewis J, Filler R, Smith DA, Golubets K, Girardi M. Lewis J, et al. Among authors: smith da. Trends Immunol. 2010 Dec;31(12):460-6. doi: 10.1016/j.it.2010.10.001. Epub 2010 Nov 9. Trends Immunol. 2010. PMID: 21071271 Free PMC article. Review.
Exploiting the PI3K/AKT pathway for cancer drug discovery.
Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Hennessy BT, et al. Among authors: smith dl. Nat Rev Drug Discov. 2005 Dec;4(12):988-1004. doi: 10.1038/nrd1902. Nat Rev Drug Discov. 2005. PMID: 16341064 Review.
Cell-cell communication in Gram-negative bacteria.
Welch M, Mikkelsen H, Swatton JE, Smith D, Thomas GL, Glansdorp FG, Spring DR. Welch M, et al. Among authors: smith d. Mol Biosyst. 2005 Sep;1(3):196-202. doi: 10.1039/b505796p. Epub 2005 Jul 25. Mol Biosyst. 2005. PMID: 16880983 Review.
A new curriculum for a new era of nursing education.
Giddens J, Brady D, Brown P, Wright M, Smith D, Harris J. Giddens J, et al. Among authors: smith d. Nurs Educ Perspect. 2008 Jul-Aug;29(4):200-4. Nurs Educ Perspect. 2008. PMID: 18770947 Review.
57 results